Literature DB >> 23662488

[Urogenital tuberculosis today].

I I Zhukova, E V Kul'chavenia, D P Kholtobin, E V Brizhatiuk, V T Khomiakov, A V Osadchiĭ.   

Abstract

In order to analyze the structure of urogenital tuberculosis, retrospective analysis of medical records of 131 patients with newly diagnosed urogenital tuberculosis observed in the Novosibirsk Regional TB Dispensary from 2009 to 2011 was performed. The renal tuberculosis is main form in the structure is urotuberculosis, detected in 75% of patients, and widespread destructive forms of the disease were diagnosed in more than half of cases. Isolated nephrotuberculosis was more often diagnosed in women--56.8%. 15.9% of patients had asymptomatic nephrotuberculosis; one-third of patients complained of pain in the lumbar region and frequent painful urination (35.2 and 39.8%, respectively); symptoms of intoxication were present in 17% of patients, renal colic--in 9.1%, and gross hematuria--in 7.9% of patients. Mycobacteriuria in isolated nephrotuberculosis was detected in 31.8% of cases. Acute tuberculous orchiepididymitis developed in 35.7% of patients, hemospermia was observed in 7.1% of patients, dysuria was in 35.7% of patients. The pain in the perineum, frequent painful urination (both by 31.6%), hemospermia (26.3%) were main complaints in prostate tuberculosis. Mycobacteria was detected in 10.5% of cases. It was found that urogenital tuberculosis has no pathognomonic symptoms; the most alarming manifestations include long-term dysuria, hematuria, hemospermia.

Entities:  

Mesh:

Year:  2013        PMID: 23662488

Source DB:  PubMed          Journal:  Urologiia        ISSN: 1728-2985


  2 in total

Review 1.  Extrapulmonary tuberculosis: are statistical reports accurate?

Authors:  Ekaterina Kulchavenya
Journal:  Ther Adv Infect Dis       Date:  2014-04

2.  Renal tuberculosis tends to be low symptoms: how to improve the diagnosis and treatment of renal tuberculosis.

Authors:  Jing Wang; Song Fan; Jun Xiao; Chao-Zhao Liang
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.